Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.


Sands B., Peyrin-Biroulet L., Loftus E., Danese S., Colombel J., Törüner M., ...More

The New England journal of medicine, vol.381, pp.1215-1226, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 381
  • Publication Date: 2019
  • Doi Number: 10.1056/nejmoa1905725
  • Title of Journal : The New England journal of medicine
  • Page Numbers: pp.1215-1226